跳至主要内容
临床试验/IRCT20130812014333N182
IRCT20130812014333N182招募中2 期

The therapeutic efficiency and immunogenic assessments of the placenta mesenchymal stem cell–derived exosomes on alleviation of symptoms in patients with lupus (a clinical trials)

Kermanshah University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Class 3 or 4 resistant lupus nephritis
  • Parenchymal lung involvement or refractory heart involvement
  • Resistant vasculitis
  • Resistant CNS involvement

排除标准

  • Other autoimmune diseases
  • Uncontrolled high blood pressure
  • Diabetes and other endocrine disorders
  • Cardiovascular failure
  • Severe renal failure and need to dialysis
  • Hepatic impairment
  • Endocarditis
  • Lupus pneumonia
  • Pregnancy and breast-feeding

研究者

相似试验